If you're not sure where to start, our Health Quiz can help guide you toward a routine that fits your goals
The mechanism is consistent across the research: resistant starch reaches the colon, gets fermented, produces SCFAs, and those SCFAs trigger gut hormone release
The dispersion between Novo and Lilly again goes to show the incredible power of competition to dictate stock outcomes: despite Novos excellent financial performance since 2023 (31% growth in 2023, 25% growth in 2024, 48% EBIT margins), the stock has declined because of competition: investors think Eli Lilly is the emerging winner within GLP-1s, given the stronger weight loss profile of tirzepatide (Mounjaro/Zepbound) versus semaglutide (Ozempic/Wegovy), and Lillys more attractive weight loss pipeline assets
The goal of this study is to outline LC 's role in human nutrition and disease, as well as to discuss the main research topics in this subject
It is studied as an NNMT inhibitor rather than a metabolic or weight-loss treatment